Vietnam Cancer Vaccines Market Size, Share, Trends and Forecast by Type, Technology, Indication, End User, and Region, 2025-2033

Vietnam Cancer Vaccines Market Size, Share, Trends and Forecast by Type, Technology, Indication, End User, and Region, 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A42452

Vietnam Cancer Vaccines Market Overview:

The Vietnam cancer vaccines market size reached USD 30.40 Million in 2024. Looking forward, the market is projected to reach USD 70.23 Million by 2033, exhibiting a growth rate (CAGR) of 9.75% during 2025-2033. The market is driven by the increasing prevalence of cancer cases, growing government healthcare investments, rising awareness about preventive healthcare measures, and the expanding adoption of advanced immunotherapy treatments. Vietnam's strengthening healthcare infrastructure and increased focus on cancer prevention programs are contributing to the Vietnam cancer vaccines market share.

Report Attribute 
Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 30.40 Million
Market Forecast in 2033 USD 70.23 Million
Market Growth Rate 2025-2033 9.75%


Vietnam Cancer Vaccines Market Trends:

Advancing Therapeutic Cancer Vaccine Technologies

The Vietnam cancer vaccines market is experiencing significant momentum driven by breakthrough developments in therapeutic vaccine technologies, particularly mRNA platforms and personalized immunotherapy approaches. For instance, in May 2025, Vietnam's VNVC Vaccine Company partnered with the Russian Direct Investment Fund to access a potential mRNA cancer vaccine, announced during General Secretary To Lam's visit to Russia. The agreement includes technology transfer and local production, aiming to provide Vietnamese patients with advanced cancer treatments and promote high-tech biomedicine collaboration. These innovative treatment modalities are revolutionizing cancer care by training the immune system to recognize and attack specific cancer cells more effectively. Vietnam's healthcare sector is gradually adopting these advanced therapeutic approaches, supported by increasing collaboration with international pharmaceutical companies and research institutions. The emergence of dendritic cell vaccines, viral vector technologies, and antigen-adjuvant combinations is creating new treatment possibilities for Vietnamese cancer patients. Healthcare providers are investing in specialized infrastructure and training programs to implement these sophisticated treatment protocols. This technological advancement is particularly significant for addressing Vietnam's high cervical and liver cancer incidence rates.

Expanding Access Through Government Healthcare Initiatives

Vietnam's commitment to expanding healthcare access is significantly driving the Vietnam cancer vaccines market growth, with substantial government investments in public health infrastructure and cancer prevention programs. The Ministry of Health has been implementing comprehensive vaccination strategies as part of the National Cancer Control Program, focusing particularly on preventive vaccines for high-prevalence cancers like cervical cancer. Government-sponsored immunization programs are being expanded beyond traditional childhood vaccinations to include adult cancer prevention initiatives. The establishment of specialized cancer treatment centers across major cities is improving access to advanced vaccine therapies, particularly in Ho Chi Minh City, Hanoi, and Da Nang. Healthcare policy reforms are streamlining the approval and distribution processes for cancer vaccines, reducing bureaucratic barriers that previously limited patient access. Public awareness campaigns are being launched to educate citizens about cancer prevention and the importance of vaccination, particularly targeting high-risk populations. For instance, in August 2025, Vietnam's Ministry of Health launched a campaign, "For a Vietnam free from the burdens of HPV," to raise awareness about HPV-related diseases and cancers. The initiative aims to promote HPV vaccination and education across the country to reduce health risks. The healthcare sector's digitization initiatives are improving patient tracking and vaccine administration efficiency across the country.

Vietnam Cancer Vaccines Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on type, technology, indication, and end user.

Type Insights

  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines

The report has provided a detailed breakup and analysis of the market by type. This includes preventive cancer vaccines and therapeutic cancer vaccines.

Technology Insights

  • Dendritic Cells Cancer Vaccines
  • Recombinant Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines
  • Viral Vector and DNA Cancer Vaccines
  • Whole-Cell Cancer Vaccines

A detailed breakup and analysis of the market based on technology have also been provided in the report. This includes dendritic cells cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, viral vector and DNA cancer vaccines, and whole-cell cancer vaccines.

Indication Insights

  • Cervical Cancer
  • Prostate Cancer
  • Others

The report has provided a detailed breakup and analysis of the market based on indication. This includes cervical cancer, prostate cancer, and others.

End User Insights

  • Pediatrics
  • Adults

A detailed breakup and analysis of the market based on end user have also been provided in the report. This includes pediatrics and adults.

Regional Insights

  • Northern Vietnam
  • Central Vietnam
  • Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Cancer Vaccines Market News:

  • In April 2025, Vietnam's Ministry of Health announced its plans to include the HPV vaccine in its national immunization program starting in 2026, amid rising cervical cancer cases. A recent campaign aimed to raise awareness, highlighting the importance of preventive measures as cervical cancer accounts for significant female cancer deaths in the country.

Vietnam Cancer Vaccines Market Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Scope of the Report

Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:

  • Type
  • Technology
  • Indication
  • End User
  • Region
Types Covered Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
Technologies Covered Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-Cell Cancer Vaccines
Indications Covered Cervical Cancer, Prostate Cancer, Others
End Users Covered Pediatrics, Adults
Regions Covered Northern Vietnam, Central Vietnam, Southern Vietnam
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the Vietnam cancer vaccines market performed so far and how will it perform in the coming years?
  • What is the breakup of the Vietnam cancer vaccines market on the basis of type?
  • What is the breakup of the Vietnam cancer vaccines market on the basis of technology?
  • What is the breakup of the Vietnam cancer vaccines market on the basis of indication?
  • What is the breakup of the Vietnam cancer vaccines market on the basis of end user?
  • What is the breakup of the Vietnam cancer vaccines market on the basis of region?
  • What are the various stages in the value chain of the Vietnam cancer vaccines market? 
  • What are the key driving factors and challenges in the Vietnam cancer vaccines market?
  • What is the structure of the Vietnam cancer vaccines market and who are the key players?
  • What is the degree of competition in the Vietnam cancer vaccines market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam cancer vaccines market from 2019-2033.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam cancer vaccines market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam cancer vaccines industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Vietnam Cancer Vaccines Market Size, Share, Trends and Forecast by Type, Technology, Indication, End User, and Region, 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials